Ixifi Description





Zuellig Pharma
Full Prescribing Info
Quantitative declaration: Each single dose vial contains 100 mg of infliximab in a 15 mL vial. After reconstitution with 10 mL of Sterile Water for Injection, each ml contains 10 mg of infliximab.
Qualitative declaration: Infliximab, is a chimeric IgG1κ monoclonal antibody (composed of human constant and murine variable regions) specific for human tumor necrosis factor-alpha (TNFα), with an identical amino acid sequence for the variable and constant regions and identical primary structure with Remicade (infliximab), the reference product. It has a molecular weight of approximately 149 kilodaltons. The manufacturing process for Infliximab drug substance uses a recombinant Chinese hamster ovary (CHO) cell line that contains the DNA encoding the sequence for infliximab and is grown in suspension culture using chemically-defined (CD), animal-derived component-free (ACF) media.
Excipients/Inactive Ingredients: Sucrose, Polysorbate 80, Disodium succinate hexahydrate, Succinic acid.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in